Antireticular cytotoxic serum is a broad therapeutic agent that accelerates fracture healing, supports postoperative recovery, and serves as an adjunct in the treatment of cancer and infection.
The disease-spectrum claim is the second pillar of Bogomolets’s promotion: ACS was distributed in Soviet medicine as a multi-indication therapeutic, not solely as an anti-aging serum. The claim is classified as refuted because the postwar Western evaluation reported by Joe Schwarcz (a late-1940s grant to Harry Goldblatt, who reviewed 3,500 cases treated at various centres) concluded that the serum ‘is not a cure for anything’. The bundle treats this as the load-bearing clinical disconfirmation event for ACS, with the caveat that the 3,500-patient evaluation has not been independently located in a NCBI-indexed primary publication and is therefore cited via Schwarcz’s modern secondary article rather than a Goldblatt-authored paper.
Appears in
Sources
- The Prolongation of Life — Bogomolets, Alexander A. *The Prolongation of Life*. Translated by Peter V. Karpovich and Sonia Bleeker. New York: Duell, Sloan and Pearce, 1946.
- The Life and Death of a Soviet-Era Search for Longevity — Schwarcz, Joe. 'The Life and Death of a Soviet-Era Search for Longevity.' McGill Office for Science and Society, 20 September 2024. First published in The Montreal Gazette.